---

Role of FNAC in the diagnosis of lymph node malignancies - An institutional experience

---

Original Article

Author Details : Chhavi Gupta*, Rajat Gupta, Subhash Bhardwaj

Volume : 8, Issue : 1, Year : 2023

Article Page : 19-22

https://doi.org/10.18231/j.achr.2023.005

Suggest article by email

Get Permission

---

Abstract

Background: Lymphadenopathy is a sign of underlying infection, primary or metastatic malignancy. Fine-needle aspiration is a simple and reliable tool for its initial investigation.
Objectives: To analyse the cytomorphological features of malignant lymph node lesions and to determine the frequency of different lymph node malignancies.
Materials and Methods: It was an observational, retrospective study conducted in the cytology section of Department of Pathology, Govt. Medical College, Jammu. It included lymph node aspirates that were reported as malignant. May-Grunwald-Giemsa (MGG) and Papanicolaou (PAP) stained smears were examined under light microscope and the cytological features were studied.
Results: A total of 97 malignant lymph node aspirates were included in this study. Metastatic malignancy accounted for maximum number of cases (78, 80.4%) followed by lymphoma (19, 19.6%). Squamous cell carcinoma was the most common metastatic malignancy and also the most frequently diagnosed malignant lesion in our study (42, 43.3%). Cervical lymph nodes were the most commonly aspirated lymph nodes.
Conclusion: FNAC of lymph nodes is a simple and valuable tool in the diagnosis of lymph node malignancies.
 

Keywords: Lymph node, FNAC, Malignant

How to cite : Gupta C, Gupta R, Bhardwaj S, Role of FNAC in the diagnosis of lymph node malignancies - An institutional experience. IP Arch Cytol Histopathol Res 2023;8(1):19-22

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.